Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
225 studies found for:    Chlormethine
Show Display Options
Rank Status Study
21 Active, not recruiting Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: doxorubicin hydrochloride;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vinblastine sulfate;   Drug: vincristine sulfate;   Radiation: radiation therapy
22 Unknown  Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: Stanford V regimen;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate
23 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: Stanford V regimen;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine sulfate;   Drug: vincristine sulfate;   Radiation: radiation therapy
24 Completed Effects of a Specific Spice on Energy Metabolism
Condition: Healthy
Interventions: Dietary Supplement: Mustard (dijon);   Dietary Supplement: Placebo
25 Active, not recruiting Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: palifosfamide-tris;   Drug: Normal Saline
26 Recruiting Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Conditions: Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Malignant Extragonadal Germ Cell Tumor;   Malignant Extragonadal Non-Seminomatous Germ Cell Tumor;   Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Ovarian Germ Cell Tumor;   Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Ovarian Germ Cell Tumor
Intervention: Drug: palifosfamide
27 Active, not recruiting Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Conditions: Transplantation, Homologous;   Transplantation, Autologous;   Multiple Myeloma;   Blood and Marrow Transplant (BMT)
Interventions: Procedure: Autologous/Allogeneic HCT;   Drug: cyclophosphamide;   Biological: filgrastim;   Drug: melphalan;   Procedure: peripheral blood stem cell transplantation;   Radiation: total nodal irradiation;   Biological: anti-thymocyte globulin;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Other: laboratory biomarker analysis
28 Completed Use of Erythromycin in Mustard-Induced Bronchiolitis
Conditions: Bronchiolitis Obliterans;   Acute Obliterating Bronchiolitis
Intervention: Drug: Erythromycin
29 Completed Use of Clarithromycin in Mustard-Induced Bronchiolitis
Conditions: Bronchiolitis Obliterans;   Acute Obliterating Bronchiolitis
Intervention: Drug: Clarithromycin
30 Recruiting A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Conditions: Ewing Sarcoma;   Gastrointestinal Tumor;   Germ Cell Tumor;   Hepatic Tumor;   Lymphoma;   Wilms Tumor;   Rhabdoid Tumor;   Clear Cell Carcinoma;   Renal Cell Carcinoma;   Melanoma;   Neuroblastoma;   Rhabdomyosarcoma;   Non-rhabdomyosarcoma
Interventions: Drug: alemtuzumab;   Drug: fludarabine;   Drug: sirolimus;   Drug: Busulfan;   Drug: melphalan;   Biological: stem cells
31 Recruiting KIR Mismatched Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy
Conditions: Leukemia;   Lymphoma
Interventions: Radiation: Total Lymphoid Irradiation;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Thiotepa;   Drug: Melphalan;   Biological: HPC,A Infusion;   Biological: TC-NK Infusion;   Biological: G-CSF;   Drug: Mesna;   Device: CliniMACS;   Drug: Mycophenylate mofetil
32 Active, not recruiting Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: melphalan;   Drug: thiotepa
33 Completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
34 Recruiting Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation
Conditions: Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Myeloid Sarcoma;   Chronic Myelogenous Leukemia (CML);   Juvenile Myelomonocytic Leukemia (JMML);   Myelodysplastic Syndrome (MDS);   Non-Hodgkin Lymphoma (NHL)
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: G-CSF;   Biological: Interleukin-2;   Drug: Melphalan;   Drug: Thiotepa;   Drug: Rituximab;   Biological: Natural killer cell therapy;   Biological: T-cell depleted HPC transplant;   Biological: CD45RA-depleted HPC transplant
35 Recruiting Combined Cord Blood and Haploidentical Transplantation for Patients With Hematologic Malignancies
Condition: Hematological Malignancies
Interventions: Drug: Cyclophosphamide;   Drug: Thiotepa;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Mesna;   Biological: G-CSF;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Drug: Methylprednisolone;   Radiation: Total lymphoid irradiation;   Biological: Lymphocyte infusions
36 Recruiting A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
Conditions: Neuroblastoma;   Lymphoma;   High-risk Tumor
Interventions: Device: CD133+ selected autologous stem cell infusion;   Biological: IL-2;   Biological: hu14.18K322A;   Drug: Busulfan;   Drug: Melphalan;   Biological: GM-CSF;   Drug: Bendamustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Carboplatin;   Device: Haploidentical natural killer cell infusion;   Biological: G-CSF;   Drug: Etoposide phosphate
37 Recruiting Therapy for Children With Advanced Stage Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: topotecan;   Biological: hu14.18K322A;   Procedure: peripheral blood stem cell harvest;   Procedure: surgical resection;   Drug: cisplatin;   Drug: etoposide;   Drug: doxorubicin;   Drug: vincristine;   Drug: busulfan;   Drug: melphalan;   Biological: peripheral blood stem cell transplantation;   Biological: natural killer cell infusion;   Radiation: radiation therapy;   Biological: GM-CSF;   Biological: G-CSF;   Drug: mesna;   Drug: levetiracetam;   Biological: interleukin-2;   Drug: Isotretinoin
38 Completed Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
Conditions: Brain Tumor;   Central Nervous System Tumor
Interventions: Biological: Sargramostim;   Drug: cyclophosphamide;   Drug: melphalan;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
39 Recruiting Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse
Condition: Multiple Myeloma in Relapse
Interventions: Drug: Melphalan;   Biological: Autologous Hematopoietic Stem cell
40 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Fludarabine monophosphate, melphalan, Bortezomib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years